National Health Investors, Inc.
NHI
$73.29
$0.881.22%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 68.87M | 65.78M | 63.32M | 65.76M | 62.19M |
| Total Other Revenue | 20.85M | 19.97M | 19.63M | 19.45M | 19.49M |
| Total Revenue | 89.71M | 85.76M | 82.94M | 85.21M | 81.68M |
| Cost of Revenue | 13.73M | -28.65M | 13.53M | 3.21M | 13.06M |
| Gross Profit | 75.99M | 114.41M | 69.41M | 82.00M | 68.62M |
| SG&A Expenses | 8.26M | 5.83M | 5.05M | 5.04M | 5.88M |
| Depreciation & Amortization | 19.16M | 18.68M | 17.77M | 17.49M | 17.51M |
| Other Operating Expenses | 269.00K | 42.35M | 83.00K | 10.48M | -187.00K |
| Total Operating Expenses | 41.41M | 38.20M | 36.43M | 36.22M | 36.25M |
| Operating Income | 48.30M | 47.55M | 46.51M | 48.99M | 45.43M |
| Income Before Tax | 33.82M | 42.79M | 28.24M | 34.95M | 30.66M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 33.82M | 42.79M | 28.24M | 34.95M | 30.66M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 348.00K | 455.00K | 298.00K | 304.00K | 290.00K |
| Net Income | 34.17M | 43.24M | 28.54M | 35.26M | 30.95M |
| EBIT | 48.30M | 47.55M | 46.51M | 48.99M | 45.43M |
| EBITDA | 67.46M | 66.23M | 64.28M | 66.48M | 62.93M |
| EPS Basic | 0.75 | 0.96 | 0.66 | 0.81 | 0.71 |
| Normalized Basic EPS | 0.47 | 0.46 | 0.46 | 0.50 | 0.45 |
| EPS Diluted | 0.74 | 0.95 | 0.65 | 0.81 | 0.71 |
| Normalized Diluted EPS | 0.47 | 0.45 | 0.46 | 0.50 | 0.45 |
| Average Basic Shares Outstanding | 45.72M | 45.12M | 43.48M | 43.40M | 43.39M |
| Average Diluted Shares Outstanding | 45.88M | 45.44M | 43.99M | 43.56M | 43.42M |
| Dividend Per Share | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 |
| Payout Ratio | 120.35% | 90.79% | 137.00% | 110.85% | 126.24% |